Our Healthcare & Life Sciences team of highly respected health consultants provides a  transformational approach to the industry.

We offer unparalleled analysis of all facets of an industry going through dramatic changes, particularly the key role that digital technologies  is playing.

We have experts who study trends and translate these into actionable growth opportunities to aid companies tackling issues such as digital health, next-gen diagnostic tools and pharma 4.0 over the coming years.

Our experts across the globe are conducting on-the-ground research and delivering comprehensive insights to help healthcare organizations identify key growth opportunities.

In just a few short years, the digital front door has shifted from being a nice-to-have online presence to being a critical part of every healthcare organization’s overarching digital health strategy. Extending well beyond a website, the digital front door consists of a federated suite of applications, services, portals, and digital devices, enabling healthcare organizations to engage patients through digital touchpoints as they journey across the continuum of care outside of brick-and-mortar facilities. The objective is to create a unified, seamless, consumer-centric patient experience that fosters behavior change while providing better healthcare access, equity, efficiency, quality, outcomes and improved patient and staff satisfaction. The digital front door can also increase brand awareness, reputation, and revenue.

The Impact of the Digital Front Door on Healthcare

The total global healthcare market is expected to reach 2.3 trillion dollar by end of 2022 and APAC will the second largest market after the US, accounting for quarter of the total healthcare market. Traditionally technology adaption in healthcare is slower compared with many other industries like information & telecommunications, retail, logistics; however, it is slowing catching up and so is the adoption of artificial intelligence. The session will look at the applications of Artificial Intelligence in drug development, clinical, diagnostics, monitoring, and operational use cases.

Healthcare Outlook and Artificial Intelligence Applications in Healthcare

Artificial intelligence (AI) applications are moving the needle in healthcare, with AI being applied in clinical, operational, and financial use cases by hospitals, radiologists, pharmaceutical companies, medical device companies, and many start-ups. This Think Tank will combine perspectives from Frost & Sullivan's industry experts, governments, investors, and vendors along with solutions that are the likely near-term and long-term winners in this space. Plus, find out what is needed to drive success in applying AI in the healthcare environment.

Attend this Think Tank to discover:

· Use cases, market potential, and business models of where AI is being applied in healthcare and life sciences organizations.
· Necessary data infrastructure and the role of technology partners in implementing and gaining value from AI in healthcare. 
· Leveraging AI to disrupt the current healthcare system versus applying AI tools within existing workflows and augmenting the roles of various stakeholders.

Data Disruption in Health Systems Transforming Healthcare

PANEL DISCUSSION: What are the Transformational Opportunities in 2022?

This panel will cover the outlook of healthcare globally and highlight the opportunities in the healthcare sub-segments of pharmaceutical/biotechnology, diagnostics, medical devices, imaging technologies, and digital health. 

Moderator: Dr. Milind Sabnis, Head of Healthcare Consulting Practice, APAC

Expert Panel:
• Unmesh Lal, Research Director, Healthcare & Life Sciences
• Siddharth Shah, Research Manager, Healthcare & Life Sciences
• Koustav Chatterjee, Global Program Lead–Digital Health

Key Challenges and Opportunities in Healthcare 2022

Koustav Chatterjee, Industry Principal at Frost & Sullivan, and Troy Ament, Chief Information Security Officer at Fortinet, will discuss:  

1. How cognitive unified endpoint management (UEM) is used to identify and resolve root causes of cyberattacks. 
2. Why it's important to secure cloud compatibility of all application programming interface (API) enforcements to ensure seamless digital transformation. 
3. How to store on-device and internet of medical things (IoMT)-generated data on a dedicated data lake to optimize protection. 
4. How to ensure cognitive patient identity and access management on the cloud.
5. How to leverage third-party security and risk advisory services to manage IoMT and medical devices.
6. How to protect virtual care ecosystems with inherent security architecture.

Top 6 Growth Opportunities for the US Healthcare Cybersecurity Industry

The pandemic has propelled the agenda of “anytime, anywhere care,” allowing for virtual and alternative models of care to emerge in the areas of primary, secondary and tertiary care. Technology-enabled primary care and chronic disease management, virtual visits and remote patient monitoring, and the shift to outpatient surgery centers are major decentralization trends. 

Join Frost & Sullivan’s expert, Siddharth Shah, for the Growth Opportunity Briefing, “Growth Opportunities Emerging from Decentralization of Care Delivery,” on October 26 at 2:30 p.m. SGT. This session will support companies seeking to understand what decentralization of care across primary, secondary and tertiary care means for the industry and how they can realign their strategies for 2021 and beyond.

Care delivery is undergoing a fundamental shift from retail settings and pharmacies to home-based. This expands the role of consumers and decision-makers in the market. Therefore, incumbent players must be prepared to tackle these new growth opportunities.  

Key benefits of attending this webinar:
• Gain an understanding of the concept of decentralization of care across primary, secondary and tertiary care and what it means to consumers and market players.
•	Explore the trends and forces driving decentralization before and during the pandemic for clearer insights into the industry.
•	Identify the key players driving the trend of decentralization and the biggest growth opportunities arising out of decentralization.

Growth Opportunities Emerging from Decentralization of Care Delivery

Major hospital systems are placing large bets that the future of hospital care will be delivered inside patients' homes. After more than a decade as a niche offering, hospital-level care at home-some of it offered digitally-is ready to rise, boosted by hospitals seeking to relieve overcrowding during the pandemic, changing patient preference, and insurers interested in lowering healthcare costs. Implementation roadblocks, including patient selection, care management and discharge for home care, will present new challenges and opportunities for a diverse hospital at home (HaH) player ecosystem. Can HaH be one of the most significant global growth opportunities in healthcare delivery, and what will impact different stakeholders?

Join Frost & Sullivan experts Kaustubh Savant and Greg Caressi for a panel discussion featuring Dr. Nick Patel, Chief Digital Officer, Prisma Health; Dr. Zenobia Brown, VP & Medical Director, Population Health, Northwell Health; and Karsten Russell-Wood, Chief Marketing Officer, EQUUM Medical. Learn from the experiences of others and walk away with actionable strategies for your organization

Questions we'll answer during the panel discussion:
• HaH has seen phenomenal adoption in the past nine months, and many expect it to continue, but where does it go from here?
• How are the health systems/hospitals overcoming implementation and scale-up challenges? 
• Frost & Sullivan's research points toward strategic partnerships with different technology and care coordination players as critical approaches. What is the commitment needed for the transition?
• Remote patient care has transformed from a niche to a significant opportunity. How are technology players like Philips helping health providers capitalize on this?

Hospital at Home—A Value-driven and Sustainable Care Model?

The dynamics of the COVID-19 pandemic, including multi-country shutdowns, put an excessive amount of pressure on healthcare supply chains worldwide. There are clear signs that the pandemic will be here in the long run, driving healthcare companies to address supply chain vulnerabilities. Pharmaceutical companies relied heavily on an unprecedented level of cooperation from raw material suppliers, government agencies, and contract development and manufacturing organizations. 

Listen to others' experiences, participate in a live, interactive question-and-answer session, and walk away with actionable strategies for your organization. 

Attend this webinar to discover:
• How the unquestionable impact of these shifts results from three merging drivers of change—coordinated management, flexible manufacturing strategies, and seamless mobility.
• Best practices to optimize supply chain networks.
• Direct-to-patient (DTP) and home care business models.
• New strategies for the medical device and pharmaceutical industries.
• Growth opportunities in a post-COVID-19 environment.
• Medical device track-and-trace solutions and re-shoring hubs.
• Cold chain capabilities for next-generation vaccines and biologics.
• Valuable insights on real-time inventory management.

Presented by

About this talk

More from this channel